Back to DE D. E. Shaw & Co., Inc.

TSHATSHA
Showing 5 of 11 quarters

Position history for DED. E. Shaw & Co., Inc.'s holdings in TAYSHA GENE THERAPIES INC

D. E. Shaw & Co., Inc. holds 4.4M shares of TSHA (TAYSHA GENE THERAPIES INC), worth $30M as of 2026-Q2. The position was decreased (-0.7% shares). TSHA represents 0.0% of D. E. Shaw & Co., Inc.'s portfolio.

Current Value

$30M

Current Shares

4.4M

Total Value Change

+$29M

Total Shares Change

+4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
4.4M
-0.7%
$30M0.0%$6.81
0
2026-Q1
Increased
4.4M
+10.3%
$19.8M0.0%$4.53
31
2025-Q4
Increased
4M
+48.3%
$22.1M0.0%$5.66
39
2025-Q3
Increased
2.7M
+574.1%
$8.9M0.0%$3.16
44
2025-Q2
New
401,509
-
$927,4860.0%$2.38
35

Other major holders of TSHA: Avoro Capital Advisors LLC, RA CAPITAL MANAGEMENT, L.P., GOLDMAN SACHS GROUP INC, FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used